Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.

The potentially pathogenic effects of infection with Epstein-Barr virus (EBV), a B-lymphotropic agent with cell growth-transforming potential, are contained in healthy virus carriers by virus-specific cytotoxic T-lymphocyte (CTL) surveillance. The target antigens against which such CTL responses are...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Proc Natl Acad Sci U S A
Asıl Yazarlar:	Murray, R J, Kurilla, M G, Griffin, H M, Brooks, J M, Mackett, M, Arrand, J R, Rowe, M, Burrows, S R, Moss, D J, Kieff, E
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	National Academy of Sciences 1990
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC53802/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2158098/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.87.8.2906
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.

Benzer Materyaller